(Q40139200)

English

Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome

scientific article published on 16 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Rupa Narayan

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Jacqueline S Garcia

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Mary-Elizabeth M Percival

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Caroline Berube

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Steve Coutre

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Jason Gotlib

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Peter Greenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Michaela Liedtke

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Rhonda Hewitt

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Kathleen Regan

10

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Charles Williamson

11

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Camille Doykan

12

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Michael H Cardone

13

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Alex McMillan

14

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Bruno C Medeiros

15

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

609-615

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: an emerging entity with a poor prognosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

A phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidine

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Failure of hypomethylating agent-based therapy in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Clonal architecture of secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1091930

21 January 2018

Identifiers

10.3109/10428194.2015.1091930

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40139200&oldid=1886717564"